Walleye Capital’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-183,306
| Closed | -$873K | – | 1838 |
|
|
2025
Q1 | $873K | Sell |
183,306
-402,944
| -69% | -$1.92M | ﹤0.01% | 891 |
|
|
2024
Q4 | $3.27M | Sell |
586,250
-275,051
| -32% | -$1.53M | 0.01% | 552 |
|
|
2024
Q3 | $5.44M | Sell |
861,301
-129,083
| -13% | -$816K | 0.01% | 422 |
|
|
2024
Q2 | $4.2M | Buy |
990,384
+724,270
| +272% | +$3.07M | 0.01% | 521 |
|
|
2024
Q1 | $1.93M | Buy |
266,114
+78,098
| +42% | +$566K | ﹤0.01% | 788 |
|
|
2023
Q4 | $942K | Buy |
+188,016
| New | +$942K | ﹤0.01% | 924 |
|
|
2020
Q2 | – | Sell |
-440
| Closed | -$23K | – | 590 |
|
|
2020
Q1 | $23K | Buy |
+440
| New | +$23K | 0.01% | 450 |
|
|
2019
Q4 | – | Sell |
-1,234
| Closed | -$70K | – | 625 |
|
|
2019
Q3 | $70K | Sell |
1,234
-1,166
| -49% | -$66.1K | ﹤0.01% | 315 |
|
|
2019
Q2 | $287K | Buy |
+2,400
| New | +$287K | 0.03% | 86 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 363 |
|